−0.023AUD
−6.24 MAUD
180.18 M
About AMPLIA THERAPEUTICS LIMITED
Sector
Industry
CEO
Christopher J. Burns
Website
Headquarters
Melbourne
Founded
2013
ISIN
AU0000023822
FIGI
BBG005M56XX7
Amplia Therapeutics Ltd. is a medical biotechnology company, which engages in the development of drugs for potential use in multiple indications including oncology and chronic fibrosis. Its immuno-modulator microparticles technology can be used to induce the human immune system to fight certain cancers and infections, or modulate certain immune mechanisms implicated in autoimmune diseases such as multiple sclerosis. The company was founded by Christopher J. Burns on May 31, 2000 and is headquartered in Melbourne, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ATX is 0.070 AUD — it has decreased by 17.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange AMPLIA THERAPEUTICS LIMITED stocks are traded under the ticker ATX.
Yes, you can track AMPLIA THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, ATX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AMPLIA THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.